Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953582152> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2953582152 endingPage "S198" @default.
- W2953582152 startingPage "S198" @default.
- W2953582152 abstract "To examine the impact of antimicrobial resistance (AMR) on pediatric pneumococcal infections in Ethiopia. We developed an agent-based model – DREAMR (Dynamic Representation of the Economics of AMR) – to assess the health and economic burden of AMR on antibiotics to treat pneumococcal diseases in Ethiopia. The model simulated children under age five with pneumococcal pneumonia, meningitis, or acute otitis media, where infected children sought care at varying health facilities and utilized antibiotic treatment. Pharmacokinetics and pharmacodynamics methods were used to determine whether bacteria died under antibiotic exposure. Dynamic resistance levels of three antibiotics (i.e., penicillin, amoxicillin, and ceftriaxone) were modeled. The cost-of-illness approach was employed to assess the burden (e.g., treatment failures, deaths, disabilities) attributable to AMR. We evaluated the economic burden that included direct and indirect medical costs, productivity losses for caretakers, and productivity losses due to premature deaths and disabilities. Preliminary results suggested that AMR led to treatment failures in almost 30% (95% CI: 25.2 – 33.6%) of first-line antibiotic therapy for pediatric pneumococcal diseases. In one year, resistance against Streptococcus pneumoniae increased by 0.5% (-0.4 – 1.3%) for amoxicillin and 0.8% (-0.1 – 1.8%) for penicillin, and reduced by 0.3% (-0.7 – 0.1%) for ceftriaxone. AMR against pneumococcal diseases contributed to around 270,000 (214,574 – 321,862) treatment failures and 1,300 (0 – 5,960) deaths. Treatment costs of AMR related pneumococcal infections were approximately $14 million ($7,130,000 – $39,522,000) annually, including $4 million ($3,087,000 – $5,273,000) for ineffective first-line treatments and $10 million ($4,043,000 – $34,249,000) for additional second-line treatments. This is the first study to develop an agent-based model to estimate the impact of AMR on treatment of pediatric pneumococcal infections in Ethiopia. Reducing misuse and overuse of antibiotics is essential to maintain the effectiveness of antibiotics and lessen the health and economic burden of AMR." @default.
- W2953582152 created "2019-07-12" @default.
- W2953582152 creator A5035718195 @default.
- W2953582152 creator A5055586846 @default.
- W2953582152 creator A5062484950 @default.
- W2953582152 creator A5088526276 @default.
- W2953582152 date "2019-05-01" @default.
- W2953582152 modified "2023-09-26" @default.
- W2953582152 title "PIN25 IMPACT OF ANTIBIOTIC RESISTANCE ON TREATMENT OF PNEUMOCOCCAL DISEASE IN ETHIOPIA: AN AGENT-BASED MODELING SIMULATION" @default.
- W2953582152 doi "https://doi.org/10.1016/j.jval.2019.04.896" @default.
- W2953582152 hasPublicationYear "2019" @default.
- W2953582152 type Work @default.
- W2953582152 sameAs 2953582152 @default.
- W2953582152 citedByCount "0" @default.
- W2953582152 crossrefType "journal-article" @default.
- W2953582152 hasAuthorship W2953582152A5035718195 @default.
- W2953582152 hasAuthorship W2953582152A5055586846 @default.
- W2953582152 hasAuthorship W2953582152A5062484950 @default.
- W2953582152 hasAuthorship W2953582152A5088526276 @default.
- W2953582152 hasBestOaLocation W29535821521 @default.
- W2953582152 hasConcept C126322002 @default.
- W2953582152 hasConcept C174802600 @default.
- W2953582152 hasConcept C177713679 @default.
- W2953582152 hasConcept C187212893 @default.
- W2953582152 hasConcept C2776152631 @default.
- W2953582152 hasConcept C2776520383 @default.
- W2953582152 hasConcept C2777914695 @default.
- W2953582152 hasConcept C2779708577 @default.
- W2953582152 hasConcept C2779892413 @default.
- W2953582152 hasConcept C2781253189 @default.
- W2953582152 hasConcept C501593827 @default.
- W2953582152 hasConcept C71924100 @default.
- W2953582152 hasConcept C86803240 @default.
- W2953582152 hasConcept C89423630 @default.
- W2953582152 hasConcept C94665300 @default.
- W2953582152 hasConceptScore W2953582152C126322002 @default.
- W2953582152 hasConceptScore W2953582152C174802600 @default.
- W2953582152 hasConceptScore W2953582152C177713679 @default.
- W2953582152 hasConceptScore W2953582152C187212893 @default.
- W2953582152 hasConceptScore W2953582152C2776152631 @default.
- W2953582152 hasConceptScore W2953582152C2776520383 @default.
- W2953582152 hasConceptScore W2953582152C2777914695 @default.
- W2953582152 hasConceptScore W2953582152C2779708577 @default.
- W2953582152 hasConceptScore W2953582152C2779892413 @default.
- W2953582152 hasConceptScore W2953582152C2781253189 @default.
- W2953582152 hasConceptScore W2953582152C501593827 @default.
- W2953582152 hasConceptScore W2953582152C71924100 @default.
- W2953582152 hasConceptScore W2953582152C86803240 @default.
- W2953582152 hasConceptScore W2953582152C89423630 @default.
- W2953582152 hasConceptScore W2953582152C94665300 @default.
- W2953582152 hasLocation W29535821521 @default.
- W2953582152 hasOpenAccess W2953582152 @default.
- W2953582152 hasPrimaryLocation W29535821521 @default.
- W2953582152 hasRelatedWork W120516359 @default.
- W2953582152 hasRelatedWork W1966272079 @default.
- W2953582152 hasRelatedWork W1975031531 @default.
- W2953582152 hasRelatedWork W2035233582 @default.
- W2953582152 hasRelatedWork W2102736695 @default.
- W2953582152 hasRelatedWork W2118307170 @default.
- W2953582152 hasRelatedWork W2159497520 @default.
- W2953582152 hasRelatedWork W2166410235 @default.
- W2953582152 hasRelatedWork W2417128434 @default.
- W2953582152 hasRelatedWork W2419071966 @default.
- W2953582152 hasVolume "22" @default.
- W2953582152 isParatext "false" @default.
- W2953582152 isRetracted "false" @default.
- W2953582152 magId "2953582152" @default.
- W2953582152 workType "article" @default.